Skip to main content
. 2022 Oct 19;128(24):4185–4193. doi: 10.1002/cncr.34498

FIGURE 2.

FIGURE 2

Comparison of BCRL rates in SAD vs AD arm at 12 months after surgery. Multimodal assessment of primary endpoint: (A) Clinical appearance of upper limb. (B) Excess volume of upper limb. (C) Lymphoscintigraphic findings. (D) Patients' self‐ratings. AD indicates axial dissection; BCRL, breast‐cancer–related lymphedema; SAD, selective axillary dissection.